Alberto V Miguel E, Zuluaga Daniela, Winter Axel, Pratschke Johann, Rau Beate, Gül Safak
Surgical Department, Charité - Universitätsmedizin Berlin, Berlin, Germany.
J Surg Oncol. 2024 Nov;130(6):1403-1421. doi: 10.1002/jso.27988. Epub 2024 Nov 18.
The main aim of this review is to analyze postoperative complications after cytoreductive surgery and intraperitoneal chemotherapy. Although the literature in this field is ever growing, reporting on complication is not a given. Nevertheless, some main risk factors such as prior surgery, high tumor burden and the center's expertize have an impact on patient outcomes. Transparency is key, if we want to continue to improve.
本综述的主要目的是分析肿瘤细胞减灭术和腹腔内化疗后的术后并发症。尽管该领域的文献不断增加,但关于并发症的报道并非必然。然而,一些主要风险因素,如既往手术史、高肿瘤负荷和中心的专业水平,会对患者的预后产生影响。如果我们想持续改进,透明度是关键。